IRCT20201130049548N1 IRCT 2020-12-19 Gorgan University of Medical Sciences Comparison of zinc and omega-3 supplementation effect on maternal and fetal outcomes in pregnant women with IUGR fetus Comparison of zinc and omega-3 supplementation effect on maternal and fetal outcomes in pregnant women with IUGR fetus with control group, a double-blind placebo controlled clinical trial study 2020-11-15 anticipated 117 Complete https://irct.ir/trial/53052 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: We use the block randomization method to randomize subjects into groups that result in equal sample sizes. We use the block size 6. From the following blocks, first select 1 by accident and divide the samples into three groups according to the order and fill the blocks A for zinc supplementation and B for omega-3 supplementation and C for placebo C C B B A A 1 A C C B B A 2 A A C C B B 3 B A A C C B 4 B B A A C C 5 C A A B B C 6, Blinding description: This study is double-blind and the medical examiner resident , medication provider and patients would not know about the type of treatment. 3 Condition 1: neonatal weight. Condition 2: Apgar score. Intervention 1: Intervention group: Zinc supplement recipients (zinc supplement in the form of tablets containing 30 mg of zinc sulfate daily for 6 weeks produced by Dineh Pharmaceutical Company). Intervention 2: Intervention group: Omega-3 supplement recipients (omega-3 supplement in the form of a tablet containing 180 mg EPA eicosopentaanoic acid and 120 mg docosahexaenoic acid DHA at a dose of 120 mg daily for 6 weeks produced by Zahravi Pharmaceutical Company). Intervention 3: Control group: Placebo recipients (made by Barij Essential Company daily for 6 weeks). Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information